RS20050954A - Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions - Google Patents

Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions

Info

Publication number
RS20050954A
RS20050954A YUP-2005/0954A YUP20050954A RS20050954A RS 20050954 A RS20050954 A RS 20050954A YU P20050954 A YUP20050954 A YU P20050954A RS 20050954 A RS20050954 A RS 20050954A
Authority
RS
Serbia
Prior art keywords
preparation
pharmaceutical compositions
bycyclo
heptane derivatives
stands
Prior art date
Application number
YUP-2005/0954A
Other languages
English (en)
Inventor
Istvan Gacsalyi
Gabor Gigler
Gyorgy Levay
Krisztina Moricz
Annamaria Simo
Gabor Szenasi
Original Assignee
Egys Gyogszergyar Rt.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egys Gyogszergyar Rt., filed Critical Egys Gyogszergyar Rt.,
Publication of RS20050954A publication Critical patent/RS20050954A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

Pronalazak se odnosi na upotrebu jedinjenja opšte formule (I), (I) gde R3 predstavlja vodonik ili hidroksi; R1 predstavlja vodonik ili alkil; i R2 predstavlja alkil i farmaceutski prihvatljive kisele adicione soli za proizvodnju farmaceutskih preparata koji imaju neurozaštitni efekat.
YUP-2005/0954A 2003-06-23 2004-06-22 Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions RS20050954A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301906A HUP0301906A3 (en) 2003-06-23 2003-06-23 Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
PCT/HU2004/000062 WO2004112769A1 (en) 2003-06-23 2004-06-22 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions

Publications (1)

Publication Number Publication Date
RS20050954A true RS20050954A (en) 2007-08-03

Family

ID=90001689

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0954A RS20050954A (en) 2003-06-23 2004-06-22 Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions

Country Status (23)

Country Link
US (1) US20060258750A1 (sr)
EP (1) EP1660063A1 (sr)
JP (1) JP2007516165A (sr)
KR (1) KR20060023997A (sr)
CN (1) CN1812778A (sr)
AU (1) AU2004248982A1 (sr)
BG (1) BG109414A (sr)
BR (1) BRPI0411772A (sr)
CA (1) CA2529254A1 (sr)
CZ (1) CZ200631A3 (sr)
EA (1) EA010868B1 (sr)
HR (1) HRP20060023A2 (sr)
HU (1) HUP0301906A3 (sr)
IL (1) IL172408A0 (sr)
IS (1) IS8239A (sr)
MX (1) MXPA05014127A (sr)
NO (1) NO20060277L (sr)
PL (1) PL378630A1 (sr)
RS (1) RS20050954A (sr)
SK (1) SK50082006A3 (sr)
UA (1) UA81052C2 (sr)
WO (1) WO2004112769A1 (sr)
ZA (1) ZA200510138B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
CZ2008602A3 (cs) * 2008-10-09 2009-11-25 Ústav chemických procesu Akademie ved Ceské republiky Zpusob a zarízení pro izolaci kyseliny tereftalové
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Also Published As

Publication number Publication date
US20060258750A1 (en) 2006-11-16
IL172408A0 (en) 2006-04-10
NO20060277L (no) 2006-01-19
EP1660063A1 (en) 2006-05-31
MXPA05014127A (es) 2006-02-24
BRPI0411772A (pt) 2006-08-08
KR20060023997A (ko) 2006-03-15
PL378630A1 (pl) 2006-05-15
AU2004248982A1 (en) 2004-12-29
HUP0301906A3 (en) 2006-03-28
BG109414A (bg) 2006-11-30
CA2529254A1 (en) 2004-12-29
HUP0301906D0 (en) 2003-08-28
JP2007516165A (ja) 2007-06-21
HUP0301906A2 (en) 2006-02-28
CN1812778A (zh) 2006-08-02
SK50082006A3 (sk) 2006-05-04
WO2004112769A1 (en) 2004-12-29
UA81052C2 (en) 2007-11-26
IS8239A (is) 2006-01-18
ZA200510138B (en) 2007-03-28
CZ200631A3 (cs) 2006-05-17
HRP20060023A2 (en) 2006-05-31
EA200600022A1 (ru) 2006-08-25
EA010868B1 (ru) 2008-12-30

Similar Documents

Publication Publication Date Title
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
GB0114286D0 (en) Nucleoside Derivatives
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
RS20050469A (en) Pyrrolopyrimidine derivatives
TW200833675A (en) Nicotinamide derivatives
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
PT1678166E (pt) Inibidores de proteína-quinase
TW200608972A (en) Aryl-pyridine derivatives
TW200728307A (en) Novel spirochromanone derivatives
MX2011012627A (es) Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
WO2006011050A3 (en) Pyridine derivatives
MY144209A (en) Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
UA94606C2 (ru) Производные тиоксантина, композиция, которая их содержит, и их применение в терапии
DE602006021539D1 (en) Morpholine als 5ht2c-agonisten
TW200630364A (en) 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200716547A (en) Piperidin-4-yl-amide derivatives
HK1146049A1 (en) Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
IL184116A0 (en) Use of thiazolidinone derivatives as antiangiogenic agents
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.